Bilaketaren emaitzak - Alessia Villani

Sonidegib: Safety and Efficacy in Treatment of Advanced Basal Cell Carcinoma nork Alessia Villani, Gabriella Fabbrocini, Claudia Costa, Massimiliano Scalvenzi

Connect to this object online.

Melanoma Screening Days During the Coronavirus Disease 2019 (COVID-19) Pandemic: Strategies to Adopt nork Alessia Villani, Gabriella Fabbrocini, Claudia Costa, Massimiliano Scalvenzi

Connect to this object online.

Real-Life Effectiveness of Vismodegib in Patients with Metastatic and Advanced Basal Cell Carcinoma: Characterization of Adverse Events and Assessment of Health-Related Quality of... nork Alessia Villani, Gabriella Fabbrocini, Milena Cappello, Claudia Costa, Massimiliano Scalvenzi

Connect to this object online.

Merkel Cell Carcinoma: Therapeutic Update and Emerging Therapies nork Alessia Villani, Gabriella Fabbrocini, Claudia Costa, Maria Carmela Annunziata, Massimiliano Scalvenzi

Connect to this object online.

Low-Dose Vismodegib as Maintenance Therapy After Locally Advanced Basal Cell Carcinoma Complete Remission: High Efficacy with Minimal Toxicity nork Massimiliano Scalvenzi, Milena Cappello, Claudia Costa, Gabriella Fabbrocini, Mariaantonietta Luciano, Alessia Villani

Connect to this object online.

The Efficacy of Sonidegib in Treating Locally Advanced Basal Cell Carcinoma Involving the Periocular Area nork Alessia Villani, Gabriella Fabbrocini, Giuseppe Micali, Luigi Fornaro, Luca Potestio, Massimiliano Scalvenzi

Connect to this object online.

Advanced Squamous Cell Carcinoma Developed on Chronic Hidradenitis Suppurativa, Successfully Treated with Cemiplimab: A Case Report nork Angelo Ruggiero, Wanda Lauro, Chiara Miano, Alessia Villani, Gabriella Fabbrocini, Claudio Marasca

Connect to this object online.

A Case of Recalcitrant Circinate Generalized (Lapière) Psoriasis Successfully Treated with Risankizumab nork Angelo Ruggiero, Wanda Lauro, Gabriella Fabbrocini, Chiara Miano, Alessia Villani, Claudio Marasca

Connect to this object online.

Long-Term Efficacy of Vismodegib After its Withdrawal and Patients' Health-Related Quality of Life Using the Dermatology Life Quality Index (DLQI) nork Alessia Villani, Matteo Megna, Gabriella Fabbrocini, Milena Cappello, Maria Antonietta Luciano, Claudia Costa, Massimiliano Scalvenzi

Connect to this object online.

Development of a Patient-Reported Outcome Measure (PROM) for Dysgeusia During Treatment With Smoothened (SMO) Inhibitors for Basal Cell Carcinomas: The SMO-iD Questionnaire nork Elisa Camela, Alessia Villani, Sonia Sofia Ocampo Garza, Claudia Costa, Gabriella Fabbrocini, Matteo Megna, Luca Potestio, Angelo Ruggiero, Massimiliano Scalvenzi

Connect to this object online.